Targeting H3K4 trimethylation in Huntington disease

M Vashishtha, CW Ng, F Yildirim… - Proceedings of the …, 2013 - National Acad Sciences
M Vashishtha, CW Ng, F Yildirim, TA Gipson, IH Kratter, L Bodai, W Song, A Lau, A Labadorf
Proceedings of the National Academy of Sciences, 2013National Acad Sciences
Transcriptional dysregulation is an early feature of Huntington disease (HD). We observed
gene-specific changes in histone H3 lysine 4 trimethylation (H3K4me3) at transcriptionally
repressed promoters in R6/2 mouse and human HD brain. Genome-wide analysis showed a
chromatin signature for this mark. Reducing the levels of the H3K4 demethylase
SMCX/Jarid1c in primary neurons reversed down-regulation of key neuronal genes caused
by mutant Huntingtin expression. Finally, reduction of SMCX/Jarid1c in primary neurons from …
Transcriptional dysregulation is an early feature of Huntington disease (HD). We observed gene-specific changes in histone H3 lysine 4 trimethylation (H3K4me3) at transcriptionally repressed promoters in R6/2 mouse and human HD brain. Genome-wide analysis showed a chromatin signature for this mark. Reducing the levels of the H3K4 demethylase SMCX/Jarid1c in primary neurons reversed down-regulation of key neuronal genes caused by mutant Huntingtin expression. Finally, reduction of SMCX/Jarid1c in primary neurons from BACHD mice or the single Jarid1 in a Drosophila HD model was protective. Therefore, targeting this epigenetic signature may be an effective strategy to ameliorate the consequences of HD.
National Acad Sciences
以上显示的是最相近的搜索结果。 查看全部搜索结果